Trials / Completed
CompletedNCT04893070
Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 173 (actual)
- Sponsor
- Direction Centrale du Service de Santé des Armées · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In April 2020, a meta-analysis on the long-term sequelae of respiratory syndromes related to seasonal coronaviruses (SARS and MERS) showed a significant alteration in quality of life, with in particular a decrease in physical and emotional capacities and a deterioration of social life. An improvement of the quality of life is evidenced after 6 months but without reaching the level usually observed in healthy people. The impact of SARS-CoV-2 infection on quality of life can be explained by the persistence of pleomorphic symptoms in the medium to long term. In the military population, the majority of SARS-CoV-2 cases present minor to moderate forms of the disease. Military personnel have living conditions that differ from those of the general population, in particular because of their geographic mobility, which may be responsible for isolation from the family. This isolation can be regular (we speak of "geographical celibacy" when the soldier is posted in a geographical area far from the family unit) and/or occasional, during missions on the national territory or outside. This singularity justifies a study on the impact of SARS-CoV-2 (COVID-19) infection on the quality of life in this specific population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaires COVID+ | * 1 questionnaire on COVID-19 symptomatology and quality of life 12 months after COVID-19 first symptoms * 1 questionnaire on quality of life 18 months after COVID-19 first symptoms |
| OTHER | Questionnaires COVID- | * 1 questionnaire on quality of life at enrollment * 1 questionnaire on quality of life 6 months after enrollment |
Timeline
- Start date
- 2021-07-15
- Primary completion
- 2022-07-04
- Completion
- 2022-07-04
- First posted
- 2021-05-19
- Last updated
- 2022-10-17
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04893070. Inclusion in this directory is not an endorsement.